- Annual Report
- Financial Report
- Consolidated Financial Statements of the Repower Group
- Comments on the consolidated financial statements of the Repower Group
- Consolidated statement of comprehensive income
- Consolidated balance sheet
- Changes in consolidated equity
- Consolidated cash flow statement
- Notes
- 1 Total operating revenue
- 2 Personnel expenses
- 3 Depreciation/amortisation and impairment
- 4 Financial income
- 5 Financial expenses
- 6 Investments in associates and partner plants
- 7 Income taxes
- 8 Earnings per share
- 9 Property, plant and equipment
- 10 Intangible assets
- 11 Other financial assets
- 12 Inventories
- 13 Receivables
- 14 Securities and other financial instruments
- 15 Positive/negative replacement values for held-for-trading positions
- 16 Cash and cash equivalents
- 17 Share capital
- 18 Non-current financial liabilities
- 19 Pension fund obligation
- 20 Provisions
- 21 Other non-current liabilities
- 22 Other current liabilities
- 23 Current financial liabilities
- 24 Information about net current assets
- 25 Transactions with related parties
- 26 Additional disclosures on financial instruments
- 27 Business combinations and disposals
- 28 Assets and liabilities held for sale
- 29 Impairment of assets
- 30 Segment reporting Group-wide information
- 31 Contingent liabilities and guarantee obligations
- 32 Obligations under leasing arrangements
- 33 Risk assessment
- 34 Events occurring after the balance sheet date
- Notes to the consolidated financial statements
- Report of the Auditors to the consolidated financial statements
- Financial Statements of Repower AG
- Appropriation of retained earnings
- Report of the Auditors
- Consolidated Financial Statements of the Repower Group
- Graphics
- Organisation chart
- Download
- Biomimetics
Consolidated balance sheet
Consolidated balance sheet
| Assets CHF thousands | Note | 31.12.2011 | 31.12.2012 | |
|---|---|---|---|---|
| Property, plant and equipment | 9 | 1,041,145 | 1,069,249 | |
| Intangible assets | 10 | 15,853 | 20,911 | |
| Investments in associates and partner plants | 6 | 40,004 | 40,501 | |
| Other financial assets | 11 | 67,054 | 63,456 | |
| Deferred tax assets | 7 | 25,430 | 23,095 | |
| Non-current assets | 1,189,486 | 1,217,212 | ||
| Inventories | 12 | 37,794 | 44,890 | |
| Receivables | 13 | 593,047 | 507,857 | |
| Current income tax receivables | 13,681 | 23,708 | ||
| Prepaid expenses and accrued income | 24 | 5,414 | 5,495 | |
| Securities and other financial instruments | 14 | 1,491 | 205 | |
| Positive replacement values held-for-trading positions | 15 | 107,204 | 138,612 | |
| Cash and cash equivalents | 16 | 339,873 | 261,900 | |
| Current assets | 1,098,504 | 982,667 | ||
| Assets of disposal groups classified as held for sale | 28 | 79,067 | 102,075 | |
| Total assets | 2,367,057 | 2,301,954 | ||
The Notes are an integral part of these consolidated financial statements.
| Liabilities and shareholders' equity CHF thousands | Note | 31.12.2011 | 31.12.2012 | |
|---|---|---|---|---|
| Share capital | 17 | 2,783 | 2,783 | |
| Participation capital | 17 | 625 | 625 | |
| Treasury shares | -16 | -16 | ||
| Retained earnings (including Group profit) | 933,099 | 946,674 | ||
| Fair value adjustment of financial instruments | -1,214 | -856 | ||
| Accumulated translation differences | -45,379 | -46,359 | ||
| Shareholders' equity excluding minority interests | 889,898 | 902,851 | ||
| Minority interests | 74,602 | 79,880 | ||
| Shareholders' equity | 964,500 | 982,731 | ||
| Non-current provisions | 20 | 26,619 | 27,827 | |
| Deferred tax liabilities | 7 | 58,875 | 55,337 | |
| Non-current financial liabilities | 18 | 565,652 | 546,500 | |
| Other non-current liabilities | 21 | 2,237 | 1,627 | |
| Non-current liabilities | 653,383 | 631,291 | ||
| Current income tax liabilities | 28,388 | 12,299 | ||
| Current financial liabilities | 23 | 48,548 | 44,396 | |
| Negative replacement values held-for-trading positions | 15 | 85,076 | 126,024 | |
| Current provisions | 19 | 21,484 | 1,335 | |
| Other current liabilities | 22 | 524,706 | 446,229 | |
| Deferred income and accrued expenses | 24 | 30,741 | 36,419 | |
| Current liabilities | 738,943 | 666,702 | ||
| Liabilities | 1,392,326 | 1,297,993 | ||
| Liabilities of disposal groups classified as held for sale | 28 | 10,231 | 21,230 | |
| Total liabilities and shareholders' equity | 2,367,057 | 2,301,954 | ||
The Notes are an integral part of these consolidated financial statements.